Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors
Neuroendocrine tumors (NETs) are a heterogeneous group of malignancies characterized by variable but most often indolent biologic behavior. Well-differentiated NETs can be broadly classified as either carcinoid or pancreatic NET. Although they have similar characteristics on routine histologic evalu...
Main Authors: | Chan, Jennifer, Kulke, Matthew |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer US
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147239/ |
Similar Items
-
Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
by: Yim, Kein-Leong
Published: (2012) -
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
by: Gao, Wei, et al.
Published: (2012) -
mTOR and Tumor Cachexia
by: Adrian P. Duval, et al.
Published: (2018-07-01) -
Targeting glutaminase and mTOR
by: Tanaka, Kazuhiro, et al.
Published: (2015) -
Targeting the mTOR pathway in Chromophobe Kidney Cancer
by: Shuch, Brian, et al.
Published: (2012)